Professor Maggie Dallman, OBE, is Vice President (International), Associate Provost (Academic Partnerships) and Professor of Immunology. In her Vice President and Associate Provost roles, Maggie is the academic lead on, respectively, the College's International Relations and Societal Engagement Strategies. For further information view:
Maggie joined Imperial College in 1994 as a lecturer in the Department of Biology, coming from the University of Oxford where she had held a Nuffield Medical Research Foundation Junior Research Fellowship followed by an MRC Senior Research Fellowship. At Imperial College she became Reader in Immunoregulation in 1996 and Professor of Immunology in 1999. Since 2001 Maggie has held a variety of senior positions at Imperial College including Head Section Immunology and Infection, Campus Dean and Deputy Principal for the Faculty of Natural Sciences, becoming Dean of the Faculty in 2008. Maggie took up her most recent roles as Associate Provost (Academic Partnerships) and Vice President (International) in January 2015 and January 2018 respectively.
Maggie participates in a broad range of external activities including: Director and Trustee of the Francis Crick Institute, Governor and Trustee Westminster School, London, International Advisory Panel Tokyo Tech University.
Research Interests: An ability to generate immune responses to invading pathogens is vital to our well being and survival yet over-vigorous or inappropriate responses can lead to debilitating or life threatening conditions such as autoimmunity (e.g. diabetes, rheumatoid arthritis) and allergy. Further, as our understanding of disease develops we find that dysregulated inflammatory responses are associated with conditions as diverse as alzheimer’s disease and obesity. An understanding of and an ability to control inappropriate immunity and inflammation lie therefore on the path to successful treatment of these varied diseases. Maggie’s own work uses a range of organisms from zebrafish (ZFIN webpage) to humans to study at the molecular, cellular and whole individual level not only the basis for disease but also potential approaches to therapy.
View the Dallman Lab website for further information.
et al., 2020, Photoswitchable gRNAs for spatiotemporally controlled CRISPR-Cas-based genomic regulation, Acs Central Science, Vol:6, ISSN:2374-7943, Pages:695-703
et al., 2019, Induction of innate cytokine responses by respiratory mucosal challenge with R848 in zebrafish, mice and humans, Journal of Allergy and Clinical Immunology, Vol:144, ISSN:0091-6749, Pages:342-345.e7
et al., 2018, Global transcriptional analysis identifies a novel role for SOX4 in 2 tumor-induced angiogenesis, Elife, Vol:7, ISSN:2050-084X
et al., 2017, p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis, Carcinogenesis, Vol:38, ISSN:1460-2180, Pages:1092-1103
et al., 2017, OPTiM: optical projection tomography integrated microscope using open-source hardware and software, Plos One, Vol:12, ISSN:1932-6203